Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
65165
|
ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer.
|
Cancer Lett |
2021-9-28 |
Pubmed
Full text
|
Human and Animal Cells
|
RBE(RCB1292)
,
TFK-1(RCB2537)
|
63822
|
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer.
|
Cancer Chemother Pharmacol |
2020-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
63795
|
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer.
|
Cancer Res Treat |
2020-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TKKK(RCB1907)
,
TGBC2TKB(RCB1130)
,
TGBC18TKB(RCB1169)
,
TGBC14TKB(RCB1186)
,
G-415(RCB2640)
,
HuCCT1(RCB1960)
|
61781
|
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
|
Mol Oncol |
2017-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC2TKB(RCB1130)
,
TGBC14TKB(RCB1186)
,
TGBC24TKB(RCB1196)
,
TGBC18TKB(RCB1169)
,
TGBC50TKB(RCB1280)
,
TGBC51TKB(RCB1281)
,
TGBC52TKB(RCB1282)
|
59664
|
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
|
Cancer Chemother Pharmacol |
2019-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
56025
|
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
|
Cancer Res Treat |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
|
54783
|
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
|
PLoS One |
2018-12-17 |
Pubmed
Full text
|
Human and Animal Cells
|
TKKK(RCB1907)
,
TGBC24TKB(RCB1196)
,
HuCCT1(RCB1960)
|
52613
|
PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.
|
Jpn J Clin Oncol |
2018-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TFK-1(RCB2537)
|
51585
|
A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
|
PLoS One |
2016-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC1TKB(RCB1129)
|
45402
|
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
|
BMC Cancer |
2014-12-5 |
Pubmed
Full text
|
Human and Animal Cells
|
TKKK(RCB1907)
,
TGBC24TKB(RCB1196)
,
HuCCT1(RCB1960)
|
38237
|
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
|
Cancer Sci |
2010-4-1 |
Pubmed
Full text
|